发明名称 |
ADMINISTRATION OF HYPOXIA ACTIVATED PRODRUGS IN COMBINATION WITH CHK1 INHIBITORS FOR TREATING CANCER |
摘要 |
<p>Cancer can be treated by administration of TH-302 in combination with a Chk1 inhibitor.</p> |
申请公布号 |
EP2793882(A1) |
申请公布日期 |
2014.10.29 |
申请号 |
EP20120860951 |
申请日期 |
2012.12.20 |
申请人 |
THRESHOLD PHARMACEUTICALS, INC. |
发明人 |
HART, CHARLES;MENG, FANYING;SUN, JESSICA |
分类号 |
A61K31/4168;A61K31/34;A61K31/4535;A61K31/5377;A61K31/5517;A61K31/665;A61K31/675;A61K45/06;A61P35/00 |
主分类号 |
A61K31/4168 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|